TNNT2 and kidney disorder: As we compared the two groups with an increase in hs-cTnT above clinical cut off (hs-cTnT 15–100 vs. hs-cTnT > 100) we found a significant differences in hospitalization rate (77.6% vs. 93.9%), proportions of “high medical urgency cases “METTS-A red” (17.5% vs 30.6%), proportions of patients with renal disease (12.5% vs 36.7%) and in 3 months mortality (16.6% vs 40.8%).